留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x

实时三维联合斑点追踪技术定量评估甲亢患者右心功能

闫天慧 汤敏 苏陈程 张霞 孙慧

闫天慧, 汤敏, 苏陈程, 张霞, 孙慧. 实时三维联合斑点追踪技术定量评估甲亢患者右心功能[J]. 分子影像学杂志, 2023, 46(6): 1021-1027. doi: 10.12122/j.issn.1674-4500.2023.06.11
引用本文: 闫天慧, 汤敏, 苏陈程, 张霞, 孙慧. 实时三维联合斑点追踪技术定量评估甲亢患者右心功能[J]. 分子影像学杂志, 2023, 46(6): 1021-1027. doi: 10.12122/j.issn.1674-4500.2023.06.11
YAN Tianhui, TANG Min, SU Chencheng, ZHANG Xia, SUN Hui. Quantitative evaluation of right heart function in hyperthyroidism patients using realtime three-dimensional combined speckle tracking technology[J]. Journal of Molecular Imaging, 2023, 46(6): 1021-1027. doi: 10.12122/j.issn.1674-4500.2023.06.11
Citation: YAN Tianhui, TANG Min, SU Chencheng, ZHANG Xia, SUN Hui. Quantitative evaluation of right heart function in hyperthyroidism patients using realtime three-dimensional combined speckle tracking technology[J]. Journal of Molecular Imaging, 2023, 46(6): 1021-1027. doi: 10.12122/j.issn.1674-4500.2023.06.11

实时三维联合斑点追踪技术定量评估甲亢患者右心功能

doi: 10.12122/j.issn.1674-4500.2023.06.11
基金项目: 

安徽省公益性技术应用研究联动计划项目 1704f0804048

芜湖市科技计划项目 2020ms3-5

详细信息
    作者简介:

    闫天慧,硕士,住院医师,E-mail: yantianhui0301@163.com

    通讯作者:

    张霞,硕士,主任医师,E-mail: yjsusd@163.com

Quantitative evaluation of right heart function in hyperthyroidism patients using realtime three-dimensional combined speckle tracking technology

  • 摘要:   目的  探讨实时三维(RT-3DE)联合二维斑点追踪技术(2D-STI)定量评估甲状腺功能亢进患者的右心功能。  方法  在我院就诊患者中选取80例甲状腺功能亢进患者,其中30例肺动脉收缩压>35 mmHg的患者被纳入甲亢肺高压组,余下的50例被纳入甲亢无肺高压组,选取同期40例健康体检人群作为对照组。经常规超声技术获得参数:右室基底段、右室中间段、右室长轴、右房上下径、右房左右径、右房收缩期面积、右心室面积变化率、三尖瓣环收缩期位移、三尖瓣瓣环的收缩期侧壁峰值速度、右室心肌做功指数、毛细血管楔形压,经RT-3DE技术获得参数:右室舒张末期容积(RVEDV)、右室舒张末期容积指数(RVEDVi)、右室收缩末期容积(RVESV)、右室收缩末期容积指数(RVESVi)、右室输出量(RVSV)、右室射血分数(RVEF),应用2D-STI技术获得参数:右心室游离壁纵向应变(GLS-FW)、右心室整体纵向应变(GLS),比较上述结果的组间差异;采用Pearson分析各参数之间的相关性。  结果  对照组、甲亢无肺高压组、甲亢肺高压组右室基底段、右室中间段、右室长轴、右房上下径、右房左右径、右房收缩期面积、毛细血管楔形压、三尖瓣环收缩期位移、三尖瓣瓣环的收缩期侧壁峰值速度、右室心肌做功指数依次增加,右心室面积变化率依次减小,且两两比较差异均有统计学意义(P < 0.05);3组RVEDV、RVESV、RVEDVi、RVESVi、RVSV依次增加,两两比较差异均有统计学意义(P < 0.05),但三者RVEF的差异无统计学意义(P>0.05);3组GLS-FW、GLS依次减小,两两比较差异均有统计学意义(P < 0.05);相关性检验分析结果显示RVEDV与RVESV、SV呈正相关关系(r=0.534、0.760,P < 0.01),RVEDV与GLS-FW、GLS呈负相关关系(r=-0.915、-0.886,P < 0.01)。  结论  RT-3DE、2D-STI参数结果显示,甲亢患者较对照组容量负荷增加,右心功能下降,同时合并肺高压和甲亢两种病理状态会使患者容量负荷进一步增加,右心功能进一步下降。RT-3DE联合2D-STI技术可以准确评估右心功能的状态,为临床评估患者病情提供技术支撑,也为进一步制定诊疗方案提供重要的理论支持。

     

  • 图  1  甲亢高压组患者(女,39岁)的右心室RT-3DE图

    Figure  1.  Right ventricular RT-3DE image of a patient (female, 39 years old) with hyperthyroidism and hypertension.

    图  2  甲亢无肺高压组患者(女,38岁)右心室2D-STI图

    Figure  2.  2D-STI image of a patient (female, 38 years old) without pulmonary hypertension in hyperthyroidism right ventricle.

    图  3  EDV与ESV、SV、GLS、GLS-FW(A~D)的相关性散点图

    Figure  3.  Scatter plot of correlation between EDV and ESV, SV, GLS, GLS-FW (A-D).

    图  4  观察者间GLS-FW(A)、GLS(B)的测量结果的Bland-Altman图

    Figure  4.  Inter-observer Bland-Altman plot of GLS-FW (A), GLS (B) measurements.

    表  1  3组患者临床资料的比较

    Table  1.   Comparison of clinical data of patients among 3 groups (Mean±SD)

    Parameters PAH group(n=30) No PAH group(n=50) Control group(n=40) χ2/t/F P
    Female[n(%)] 22(73.3) 36(72.0) 29(72.5) 0.008 0.992
    Age (year) 38.6±9.36 39.38±11.27 40.9±9.23 0.479 0.620
    Systolic pressure (mmHg) 134.67±14.95 132.64±12.17 131.55±14.28 0.454 0.636
    Diastolic pressure (mmHg) 77.33±9.72 80.8±8.6 81.08±11.3 1.503 0.227
    Heart rate (b/min) 101.43±17.3*# 94.72±14.99* 71.18±11.3 44.965 < 0.001
    Height (cm) 164.2±9 164.72±8.19 163.83±7.5 0.136 0.873
    Weight (kg) 58.64±9.28 61.26±12.78 61.63±9.86 0.725 0.487
    BMI (kg/m2) 21.86±3.74 22.5±4.04 22.92±2.98 0.719 0.489
    Disease duration (year) 4.31±6.06 3.19±4.74 0.858 0.357
    FT3 (pmol/L) 24.78±6.32# 19.4±5.62 15.61 < 0.001
    FT4 (pmol/L) 41.99±13.83# 33.89±10.9 8.456 0.005
    TRAB 21.88±12.65# 10.94±12.18 14.92 < 0.001
    *P < 0.05 vs control group, #P < 0.05 vs no PAH group. PAH: Hyperthyroidism with pulmonary hypertension; No PAH: Hyperthyroidism without pulmonary hypertension FT3: Free triiodothyronine; FT4: Free thyroxine; TRAB: Thyroid stimulating hormone receptor antibody.
    下载: 导出CSV

    表  2  各组常规超声心动图结果的比较

    Table  2.   Comparison of conventional echocardiographic results among different groups (Mean±SD)

    Parameters PAH group(n=30) No PAH group(n=50) Control group(n=40) F P
    RV-D1 (mm) 37.33±3.28*# 34.15±4.44* 31.12±4.27 19.543 < 0.001
    RV-D2 (mm) 29.64±3.5*# 27.16±4.89* 23.67±4.13 16.985 < 0.001
    RV-D3 (mm) 68.72±5.26*# 64.56±6.22* 57.9±5.26 32.936 < 0.001
    RA-D1 (mm) 51.33±5.32*# 47.97±5.39* 45.62±5.1 10.068 < 0.001
    RA-D2 (mm) 41.25±4.27*# 38.73±4.47* 36.65±5.18 8.318 < 0.001
    S (mm2) 16.44±5.41*# 14.23±4.43* 12.25±3.67 7.565 0.001
    FAC (%) 0.44±0.07*# 0.48±0.07* 0.51±0.05 9.903 < 0.001
    TAPSE (mm) 23.62±7.16*# 18.94±5.1* 13.8±2.53 32.609 < 0.001
    sʼ (cm/s) 18.47±2.61*# 16.31±2.59* 15.24±2.17 15.285 < 0.001
    MPI 58.61±9.04*# 54.17±9.1* 36.06±7.29 74.274 < 0.001
    PCWP (mmHg) 17.91±3.86*# 13.47±2.84* 12.16±3.74 25.767 < 0.001
    *P < 0.01 vs control group; #P < 0.01 vs no PAH group. RV-D1: Right ventricular basal segment; RV-D2: Middle segment of right ventricle; RV-D3: Right ventricular long axis; RA-D1: Right atrial superior and inferior diameter; RA-D2: Right atrial left-right diameter; S: Right atrial systolic area; RVFAC: Right ventricular area change rate; TAPSE: Systolic displacement of tricuspid annulus; sʼ: Peak systolic sidewall velocity of tricuspid annulus; MPI: Right ventricular myocardial work index; PCWP: Capillary wedge pressure.
    下载: 导出CSV

    表  3  各组RT-3DE结果的比较

    Table  3.   Comparison of RT-3DE results among 3 groups (Mean±SD)

    Parameters PAH group(n=30) No PAH group(n=50) Control group(n=40) F P
    RVEDV(mL) 115.51±17.29*# 105.34±14.56* 93.1±13.83 19.434 < 0.001
    RVEDVi(mL/m2 73.8±13.38*# 65.07±10.94* 57.53±10.8 14.127 < 0.001
    RVESV(mL) 54.74±11.82*# 50.92±3.45* 47.2±8.6 7.592 0.001
    RVESVi(mL/m2 35.01±8.72*# 31.54±4.17 * 29.13±6.15 6.367 0.002
    RVSV(mL) 60.77±13.97*# 54.42±15.21* 45.9±10.64 10.717 < 0.001
    RVEF(%) 0.54±0.13 0.5±0.08 0.49±0.08 1.524 0.222
    *P < 0.05 vs control group; #P < 0.05 vs no PAH group. RVEDV: Right ventricular end diastolic volume; RVESV: Right ventricular end systolic volume; RVEDVi: Right ventricular end- diastolic volume index; RVESVi: Right ventricular end- systolic volume index; RVSV: Right ventricular stroke volume; RVEF: Right ventricular ejection fraction.
    下载: 导出CSV

    表  4  各组2D-STI结果的比较

    Table  4.   Comparison of 2D-STI results for each group

    Parameters PAH(n=30) No PAH(n=50) Control group(n=40) F P
    GLS-FW 17.24±1.51*# 18.3±1.74 * 21.07±2.1 43.526 < 0.001
    GLS 19.23±1.51*# 20.12±1.7* 21.29±1.52 14.74 < 0.001
    *P < 0.01 vs control group; #P < 0.01 vs no PAH group. GLS-FW: Longitudinal strain of ventricular free wall; GLS: Right ventricular global longitudinal strain.
    下载: 导出CSV
  • [1] Kim HJ, Kang T, Kang MJ, et al. Incidence and mortality of myocardial infarction and stroke in patients with hyperthyroidism: a nationwide cohort study in Korea[J]. Thyroid, 2020, 30(7): 955-65. doi: 10.1089/thy.2019.0543
    [2] Zhou M, Tan J, Liu J, et al. Changes in left ventricular function and contractile homogeneity in young adults with newly diagnosed hyperthyroidism due to Graves' disease[J]. J Clin Ultrasound, 2020, 48(4): 216-21. doi: 10.1002/jcu.22802
    [3] Medvedofsky D, Koifman E, Jarrett H, et al. Association of right ventricular longitudinal strain with mortality in patients undergoing transcatheter aortic valve replacement[J]. J Am Soc Echocardiogr, 2020, 33(4): 452-60. doi: 10.1016/j.echo.2019.11.014
    [4] Kim M, Lee HJ, Park JB, et al. Correction to: preoperative right ventricular free-wall longitudinal strain as a prognosticator in isolated surgery for severe functional tricuspid regurgitation[J]. J Am Heart Assoc, 2021, 10(12): e019856.
    [5] Carrion LJBM, Sperotto A, Nazario R, et al. Impaired right ventricular function in heart transplant rejection[J]. Arquivos Brasileiros De Cardiol, 2020, 114(4): 638-44.
    [6] 李传稳. 实时三维超声心动图技术评估COPD患者右心结构及功能变化[J]. 慢性病学杂志, 2020, 21(2): 214-7. https://www.cnki.com.cn/Article/CJFDTOTAL-YYSO202002016.htm
    [7] Li XY, Dong YY, Zheng C, et al. Assessment of real-time threedimensional echocardiography as a tool for evaluating left atrial volume and function in patients with type 2 diabetes mellitus[J]. Aging, 2021, 13(1): 991-1000. doi: 10.18632/aging.202218
    [8] 韩炫, 朱文晖, 陈文娟. 心肌声学造影和二维斑点追踪技术评估冠心病患者心肌灌注与收缩功能[J]. 中南大学学报: 医学版, 2021, 46 (11): 1233-40. doi: 10.11817/j.issn.1672-7347.2021.200637
    [9] Ata F, Khan AA, Yousaf Z, et al. The clinical characteristics and outcomes of patients with pulmonary hypertension in association with hyperthyroid state: a systematic review[J]. Medicine, 2022, 101(26): e29832. doi: 10.1097/MD.0000000000029832
    [10] 中华医学会超声医学分会超声心动图学组. 中国成年人超声心动图检查测量指南[J]. 中华超声影像学杂志, 2016, 25(8): 645-66. doi: 10.3760/cma.j.issn.1004-4477.2016.08.001
    [11] Hughes K, Eastman C. Thyroid disease: long-term management of hyperthyroidism and hypothyroidism[J]. Aust J Gen Pract, 2021, 50 (1/2): 36-42.
    [12] Chung SK, Asban A, Hur J, et al. Hyperthyroidism symptoms, management, and outcomes in children and adults seeking definitive surgical treatment[J]. Ann Surg, 2021, 273(5): e181-2. doi: 10.1097/SLA.0000000000004053
    [13] Tun HN, Almaghraby A, Kavalerchyk V, et al. Acute right ventricular failure: pathophysiology, diagnostic approachwith emphasis on the role of echocardiography[J]. Curr Cardiol Rev, 2023, 19(4): e93671308.
    [14] Harjola VP, Mebazaa A, Čelutkienė J, et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology[J]. Eur J Heart Fail, 2016, 18(3): 226-41. doi: 10.1002/ejhf.478
    [15] Dissabandara T, Lin K, Forwood M, et al. Validating real-time three-dimensional echocardiography against cardiac magnetic resonance, for the determination of ventricular mass, volume and ejection fraction: a meta-analysis[J]. Clin Res Cardiol, 2023. doi: 10.1007/s00392-023-02204-5.
    [16] Song XQ, Yang K, Chen GZ, et al. Characteristics and risk factors of pulmonary hypertension in patients with hyperthyroidism[J]. Endocr Pract, 2021, 27(9): 918-24. doi: 10.1016/j.eprac.2021.02.011
    [17] Haentjens P, Van Meerhaeghe A, Poppe K, et al. Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies[J]. Eur J Endocrinol, 2008, 159(3): 329-41. doi: 10.1530/EJE-08-0110
    [18] Zuhur SS, Baykiz D, Kara SP, et al. Relationship among pulmonary hypertension, autoimmunity, thyroid hormones and dyspnea in patients with hyperthyroidism[J]. Am J Med Sci, 2017, 353(4): 374-80. doi: 10.1016/j.amjms.2017.01.016
    [19] McDermott MT. Hyperthyroidism[J]. Ann Intern Med, 2020, 172 (7): ITC49. doi: 10.7326/AITC202004070
    [20] Okosieme OE, Taylor PN, Evans C, et al. Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study[J]. Lancet Diabetes Endocrinol, 2019, 7 (4): 278-87. doi: 10.1016/S2213-8587(19)30059-2
    [21] Napoli R, Biondi B, Guardasole V, et al. Impact of hyperthyroidism and its correction on vascular reactivity in humans[J]. Circulation, 2001, 104(25): 3076-80. doi: 10.1161/hc5001.100621
    [22] Sarah H, Garrett C, Diana G, et al. Right heart failure in the setting of thyrotoxic valvulopathy: the pathophysiology of an often neglected diagnosis: a case report[J]. Eur Heart J Case Rep, 2022, 6 (9): ytac305. doi: 10.1093/ehjcr/ytac305
    [23] Yuchi Y, Suzuki R, Higuchi R, et al. Utility of real-time threedimensional echocardiography for the assessment of right ventricular morphology and function in large animal models[J]. J Clin Med, 2022, 11(7): 2001. doi: 10.3390/jcm11072001
  • 加载中
图(4) / 表(4)
计量
  • 文章访问数:  36
  • HTML全文浏览量:  26
  • PDF下载量:  7
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-08-26
  • 网络出版日期:  2023-12-26
  • 刊出日期:  2023-11-20

目录

    /

    返回文章
    返回

    关于《分子影像学杂志》变更刊期通知

    各位专家、作者、读者:

    为了缩短出版时滞,促进科研成果的快速传播,我刊自2024年1月起,刊期由双月刊变更为月刊。本刊主要栏目有:基础研究、临床研究、技术方法、综述等。

    感谢各位专家、作者、读者长期以来对我刊的支持与厚爱!

    南方医科大学学报编辑部

    《分子影像学杂志》

    2023年12月27日